CaaMTech

  • Updates
  • Our Team
  • About
  • Contact

Updates

May 9, 2022

“Minor” Magic Mushroom Compound Crystal Structure Solved

While psilocybin continues to receive attention as the active ingredient in magic mushrooms, CaaMTech scientists have continued filling the unmet …

A ball and stick model of the chemical structure of baeocystin

March 15, 2022

CaaMTech Solves Serotonin Crystal Structure

CaaMTech scientists have followed up their foundational research into the crystal structures of nine serotonin analogues by solving the crystal …

A diagram showing the molecular structure of serotonin

February 17, 2022

Bob Discordia Joins CaaMTech as Chief Scientific Officer

ISSAQUAH, WA – February 17, 2022 – CaaMTech, Inc., announced today that the company has appointed Robert (Bob) Discordia, Ph.D. …

November 16, 2021

CaaMTech Teams Up with University of Wyoming to Study Psychedelics as Treatments for Addiction

Scientists will assess the potential of psychedelic compounds for treating addiction

September 15, 2021

CaaMTech Solves Crystalline Forms of Nine Serotonin Analogs

Serotonin is a tryptamine-based human neurotransmitter responsible for a variety of complex biological functions

September 8, 2021

CaaMTech Raises $22 Million for Psychedelic Drug Discovery and Development

CaaMTech, Inc., a leading psychedelic drug discovery company, has today announced the completion of a $22 million Series A financing …

May 3, 2021

CaaMTech CEO Chadeayne to Speak at 2021 Psychedelic Therapeutics & Drug Development Conference

Dr. Andrew Chadeayne will speak about filling the unmet need for pure, well-characterized tryptamines

April 13, 2021

CaaMTech Furthers 5-MeO-DMT Research with Orally Active 5-MeO-DPT

5-MeO-DPT is a structural analog of 5-MeO-DMT, the “God molecule”

5-MeO-DPT Freebase and Fumarate

March 22, 2021

CaaMTech Synthesizes Water-Soluble ‘Foxtrot’ Salt

5-MeO-DALT fumarate is the latest novel compound from CaaMTech and UMass Dartmouth’s Manke Lab

March 10, 2021

USPTO Publishes “Alkyl Quaternary Ammonium Tryptamines and Their Therapeutic Uses”

CaaMTech’s latest published patent application covers important, yet understudied tryptamine compounds

Alkyl Quaternary Ammonium Tryptamines and Their Therapeutic Uses

Posts navigation

← older
CaamTech
  • LinkedIn
  • Facebook
  • Twitter
  • CaaMTech
    • Contact
    • About CaaMTech
    • Updates

Get CaaMTech Updates in your Inbox

© Copyright 2022 CaaMTech. All rights reserved.